Pfizer Inc. buy BMO Capital Markets
Start price
09.03.26
/
50%
€23.00
Target price
09.03.27
-
Performance (%)
0.61%
Price
07.08.26
€23.14
Summary
This prediction is currently active. The BUY prediction by BMO_Capital_Markets for Pfizer Inc. is nearly unchanged. This prediction currently runs until 09.03.27. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Pfizer Inc. | 6.588% | 6.588% |
| iShares Core DAX® | 2,57 % | 3,50 % |
| iShares Nasdaq 100 | 4,86 % | 0,65 % |
| iShares Nikkei 225® | 5,59 % | -0,25 % |
| iShares S&P 500 | 3,25 % | 2,08 % |
Comments by BMO_Capital_Markets for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer (PFE) had its "outperform" rating reaffirmed by BMO Capital Markets.
Ratings data for PFE provided by MarketBeat